wegovy glp-1 receptor agonist hydration effects 2025 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 Receptor Agonist Market Growth

Retatrutide stands out because it is a triple agonist

Due to their preclinical testing and lack of comparison with other dual receptor agonists such as tirzepatide, further studies are needed to determine whether the effects of these unimolecular compounds are superior to those of clinically tested drugs

In addition to some safety concerns, weight regain is one of the biggest issues critics voice in using drugs like Ozempic and Wegovy for weight loss

Clinical trials showed modest results, and AOD-9604 was not pursued through full FDA drug approval

Nonetheless, these clinical trials were underpowered to detect rare events such as suicidal ideation and self-injurious behavior, and they systematically excluded patients with psychiatric comorbidities commonly seen in clinical settings

There are four phases of hair growth